Acusphere, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Acusphere, Inc. - overview

Established

1993

Location

Lexington, MA, US

Primary Industry

Pharmaceuticals

About

Acusphere, Inc. is a healthcare company focused on innovative solutions for wellness. It specializes in developing products that enhance consumer health, including CBD solutions and menstrual health items designed to improve quality of life. Acusphere, Inc.


was founded in 1993 in Lexington, US, and operates in the health and wellness sector. The company has undergone strategic pivots to focus on consumer health products. It has completed a total of 5 deals, with the most recent deal occurring on October 8, 2003. The company raised USD 52.


50 mn during its initial public offering, which marked a significant funding milestone. Acusphere, Inc. specializes in the health and wellness sector, offering a diverse range of products tailored to meet the needs of consumers seeking to enhance their overall well-being. The company primarily provides CBD products such as oils, capsules, and topical applications aimed at alleviating chronic pain and stress.


Additionally, Acusphere, Inc. offers menstrual health solutions, including absorbent underwear and swimwear designed for comfort and efficacy during menstruation, primarily targeting urban markets in France as well as expanding to other European regions. In the most recent year, 2007, Acusphere, Inc. reported a revenue of USD 2.


67 mn, along with an EBITDA of USD -44. 93 mn, reflecting the company's financial position within the health and wellness market. Acusphere, Inc. is focusing on several growth initiatives, including the design and launch of new product lines aimed at health enhancement.


The company plans to expand into additional European markets by 2025. Recent funding from its October 2003 IPO will support these initiatives, helping to finance product development and market expansion efforts.


Current Investors

Burrill & Company

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development, Biomaterials

Website

www.acusphere.com

Company Stage

Mature

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.